$0.35
1,650.00%
NYSE, Aug 11, 03:30 pm CET
ISIN
US2362721001
Symbol
DNMR
Sector
Industry

Key metrics

Basic
Market capitalization
$450.0k
Enterprise Value
$366.2m
Net debt
$365.7m
Cash
$22.2m
Shares outstanding
3.0m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.0 | 0.0
EV/Sales
9.8 | 7.8
EV/FCF
negative
P/B
0.0
Financial Health
Equity Ratio
39.8%
Return on Equity
-55.9%
ROCE
-14.0%
ROIC
-14.1%
Debt/Equity
1.8
Financials (TTM | estimate)
Revenue
$37.4m | $46.9m
EBITDA
$-79.6m | $-35.7m
EBIT
$-86.9m | $-65.3m
Net Income
$-111.2m | $-92.7m
Free Cash Flow
$-71.9m
Growth (TTM | estimate)
Revenue
-26.7% | 0.5%
EBITDA
28.6% | 69.3%
EBIT
30.0% | 47.9%
Net Income
22.8% | 40.4%
Free Cash Flow
22.1%
Margin (TTM | estimate)
Gross
-63.9%
EBITDA
-212.8% | -76.1%
EBIT
-232.1%
Net
-297.1% | -197.6%
Free Cash Flow
-192.0%
More
EPS
$-37.2
FCF per Share
$-23.8
Short interest
18.4%
Employees
257
Rev per Employee
$180.0k
Show more

Is Danimer Scientific a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,027 stocks worldwide.

Danimer Scientific Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Danimer Scientific forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Danimer Scientific forecast:

Hold
50%
Sell
50%

Financial data from Danimer Scientific

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
37 37
27% 27%
100%
- Direct Costs 61 61
19% 19%
164%
-24 -24
2% 2%
-64%
- Selling and Administrative Expenses 39 39
45% 45%
104%
- Research and Development Expense 17 17
13% 13%
45%
-80 -80
29% 29%
-213%
- Depreciation and Amortization 7.23 7.23
43% 43%
19%
EBIT (Operating Income) EBIT -87 -87
30% 30%
-232%
Net Profit -111 -111
23% 23%
-297%

In millions USD.

Don't miss a Thing! We will send you all news about Danimer Scientific directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Danimer Scientific, Inc. operates as a next generation bioplastics company. It focuses on the development and production of biodegradable materials. The firm sells its products under the brand name Nodax. Its applications for biopolymers include additives, aqueous coatings, fibers, filaments, films, and injection-molded articles. The company was founded on January 13, 2014 and is headquartered in Bainbridge, GA.

Head office United States
CEO Richard Altice
Employees 257
Founded 2014
Website www.liveoakacq.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today